is there a tirzepatide shortage The FDA has declared an end to the two-year of tirzepatide, the substance in the popular weight-loss medication Zepbound and the diabetes drug Mounjaro — meaning that far more people could Addressing the Weight Loss Injectable

This is the Tmax, the time to maximum concentration

The role of amylin in the insulin resistance of non-insulin-dependent diabetes mellitus

The evidence presented in the 2 ITCs (second- and third-line) overall does not refute the conclusion that semaglutide is more efficacious than placebo but suggests the conclusion that semaglutide may be superior to other diabetes treatments in terms of efficacy

In April 2026, the primary patents for semaglutide expired, a development that may facilitate the entry of generic products into the market and influence the medications price and accessibility

Patients with thyroid conditions need providers who understand the relationship between GLP-1 medications and thyroid function